Preservative-free Fixed-dose Combination of Tafluprost 0.0015% / Timolol 0.5% in Patients With Open-angle Glaucoma or Ocular Hypertension: Clinical Effectiveness, Tolerability and Safety in a Real World Setting

Name: Preservative-free Fixed-dose Combination of Tafluprost 0.0015% / Timolol 0.5% in Patients With Open-angle Glaucoma or Ocular Hypertension: Clinical Effectiveness, Tolerability and Safety in a Real World Setting
License: Public Domain

Santen Pharmaceutical (Taiwan) Co., LTD

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

ocular surface disease, primary open angle glaucoma

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 249721
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.